PubRank

Janet C Lindsey

Author PubWeight™ 27.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Subtypes of medulloblastoma have distinct developmental origins. Nature 2010 5.94
2 Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 2012 4.13
3 beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 2005 2.84
4 Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle 2006 2.37
5 Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol 2014 1.56
6 Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol 2013 1.43
7 Rapid diagnosis of medulloblastoma molecular subgroups. Clin Cancer Res 2011 1.33
8 DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol 2013 1.27
9 The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma. Brain Res Mol Brain Res 2004 1.17
10 Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2. Neuro Oncol 2008 1.07
11 Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Cancer Res 2002 0.99
12 TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomas. J Clin Oncol 2011 0.96
13 Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types. Acta Neuropathol 2013 0.89
14 Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma. Cancer Lett 2004 0.87
15 RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell lines. Neuro Oncol 2011 0.80
16 APC and CTNNB1 mutations are rare in sporadic ependymomas. Cancer Genet Cytogenet 2006 0.76